Ocular Therapeutix eyes a $24M Series D extension | Wall Street Beat

MassDevice.com Wall Street Beat

Ocular Therapeutix said it closed a $23.8 million Series D extension round from existing backers for its sustained drug release technology to treat eye diseases.

The Bedford, Mass.-based medical device company said all of its current institutional investors ponied up for the round, including Polaris Ventures, Versant Ventures, SV Life Sciences, Sparta LLC, and Ascension Health Ventures.

Ocular Therapeutix is developing a punctum plug for the entry of the tear duct to release drug therapy to the surface of the eye over several months.

Sign up to get our free newsletters delivered straight to your inbox

President & CEO Amar Sawhney told MassDevice.com that the company plans to use the funds to back clinical trials of the device and hopes to then commercialize the technology in the U.S.

"There are many punctum plug-based products. We’re focused on glaucoma and post-operative inflammation using a steroid," Sawhney told us. "Generally speaking, we would be doing Phase II trials for both of those indications next year. We would potentially be doing Phase III trials and after that, obviously, [FDA] submission would take place."

Ocular Therapeutix is also awaiting word from the federal watchdog agency on the pre-market approval application for its ReSure sealant, a hydrogel used to protect ocular incisions following eye surgery.

"We’re very excited. We expect to have some sort of approval some time later this year," Sawhney said.

 Organovo drums up $8M
Tissue engineering firm Organovo raised nearly $7.7 million from a group of 109 unnamed investors.
Read more

 iRobot shares soar on FDA clearance for RP-VITA remote presence ‘bot

Shares of iRobot (NSDQ:IRBT)
jumped nearly 20% last week on the heels of FDA clearance for the RP-VITA remote presence robot it co-developed with InTouch Health. IRBT shares jumped 19.1% to a peak of $23.85 on Jan. 25; shares were trading at $23.50 as of about 2:0 p.m. today, up 1.1%.

 Given Imaging lands reimbursement code
Given Imaging (NSDQ:GIVN) said it won a new reimbursement code for its SmartPill gastroenteric imaging device. The 2013 National Average Medicare Physician Fee for the device is $1,188.93. GIVN shares were up 6.0% to $16.80 apiece as of about 2:30 p.m. today.
Read more

 Cardica’s back in NASDAQ’s good graces

Cardica (NSDQ:CRDC) said it’s back in compliance with the NASDAQ stock exchange’s market capitalization minimum of $50 million. CRDC shares were down 1.9% to $1.53 each as of about 2:20 p.m. today for a market cap of $56.5 million.
Read more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): Leerink Swann reiterates "market perform" rating, raises price target to $32-$34 from $30.
  • Allergan (NYSE:AGN): Bank of America Merrill Lynch raises price target from $106 to $110, maintains “buy” rating.
  • Baxter (NYSE:BAX): Leerink Swann maintains "outperform" rating, $74 price target.
  • Covidien (NYSE:COV): Barclays Equity Research reiterates "overweight" rating, $64 price target; Citigroup reiterates "buy" rating, raises price target from $64 to $71; Goldman Sachs reiterates "neutral" rating, raises price target from $63 to $66; Leerink Swann maintains "outperform" rating, raises price target to $71 from $65.
  • Haemonetics (NYSE:HAE): Barrington downgrades from “outperform” to “market perform” rating.
  • Intuitive Surgical (NSDQ:ISRG): Barrington maintains “outperform” rating, $650 price target; Cantor Fitzgerald maintains "hold" rating, raises price target from $525 to $550.
  • Medtronic (NYSE:MDT): Wunderlich Securities downgrades from “buy” to “hold” rating, maintains $46 price target.
  • ResMed (NYSE:RMD): Bank of America downgrades from “buy” to “neutral” rating.
  • Sirona Dental Systems (NSDQ:SIRO): Cantor Fitzgerald reiterates "buy" rating, raises price target from $72 to $75.
  • St. Jude Medical (NYSE:STJ): Leerink Swann reiterates "outperform" rating, ~$50 price target; TheStreet Ratings reiterates "hold" rating.
  • Stryker (NYSE:SYK): Leerink Swann maintains "outperform" rating, raises price target to $74 from $61.

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply